Wednesday, 28 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14759
Articles
Company
Drug
Laekna Therapeutics Reports Phase II Data for Afuresertib in Platinum-Resistant Ovarian Cancer
February 10, 2025
Company
Deals
Zhaoke Ophthalmology Strikes Distribution Deal with South Korea’s Kwangdong Pharmaceutical for Brimochol PF
October 24, 2024
Company
Drug
Yantai Dongcheng’s Radiopharmaceutical 68GaLNC1007 Gets FDA Nod for Diagnostic Use in Solid Tumors
October 24, 2024
Company
Deals
Joincare Pharmaceutical Partners with QYuns Therapeutics for Exclusive Rights to QX008N in China and Hong Kong
October 24, 2024
Company
Deals
Formosa Pharmaceuticals Strikes Licensing Deal with Cristália for Ocular Surgery Pain Treatment in Brazil
October 24, 2024
Company
Lonza Announces Factory Closures in the US and China Amid Global Network Optimization
October 24, 2024
Company
Policy / Regulatory
China-Based Biotechs Respond to US House Bill Limiting Federal Funding for ‘Concerning’ Companies
October 24, 2024
Company
Drug
Eisai’s Alzheimer’s Drug Leqembi Earns Marketing Approval in China
October 28, 2024
Company
Deals
Wuxi National Hi-Tech District Welcomes Synthetic Biology Industrial Park and East China’s First R&D Center
October 25, 2024
Company
Deals
Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories
October 25, 2024
Company
Drug
Henlius Biotech Ships First International Batch of HanSiZhuang for Cancer Treatment to Indonesia
October 25, 2024
Company
Drug
Shanghai Fosun Pharmaceutical Receives NMPA Approval for Phase II Study of FCN-338 for Light Chain Amyloidosis
October 25, 2024
1
2
…
800
801
802
803
804
…
1,229
1,230
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?